Be the new

Senior R&D Device Project Manager

in a biotech company focused on the discovery, design and development of innovative peptide-based medicines

Zealand Pharma A/S (Zealand) is a fast-growing Copenhagen-based biotechnology company focused on the discovery and development of peptide-based medicine and a highly attractive pipeline. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. We are passionate about improving the quality of life for patients with metabolic and gastrointestinal diseases, and other specialty or rare disease areas with significant unmet medical needs.

The position

Zealand Pharma is seeking a Senior R&D Device Project Manager with solid experience in medical device development. Reporting to Vice President, Device Development, Lars Stenholt, you will leverage your project management experience in setting the direction for the team and securing the project process targeting our highly ambitious goals. So, if you are passionate for driving medical device development and are highly motivated by understanding the user-situation and user-needs, you might be exactly what we are looking for. Further, the positions include:

Candidate profile

Ideally, you hold a degree within a relevant field such as engineering, biochemistry, pharmaceutical science or similar, combined with 5+ years of project management experience within medical device development. Additionally, we imagine that you:

Our work environment provides a high degree of independency thus you need to have an ambitious and proactive attitude towards your work as you drive new and innovative solutions to the market. You are also an outstanding collaborator, who puts team performance over individual contributions, have a no-blame, and go-getter attitude.

Who are we?

The Device Development & Manufacturing team is characterized by an informal atmosphere with emphasis on an inspiring, lively, and engaging working environment. While we are a high performing team and deeply dedicated to our tasks, we maintain focus on having a fun, inclusive-, and flexible work culture. As a small company, we support each other’s tasks flexibly and have all ‘hands on deck’ when required. We support the entire Zealand peptide portfolio, and work with international partners to develop the best possible delivery devices for each of our products.

What we offer

Our employees are fundamental to our success, and we continue to be able to attract and retain people with vast experience and talent. We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.

Zealand Pharma DNA builds on four values: (1) We are bold, (2) We empower people, (3) We work as one team, and (4) We can be trusted.

Our work environment is characterized by strong cross functional teamwork, room for individual performance and development, informality and respect, high work-ethics and engagement-, and fun. Often, we forget the structures and hierarchies, we roll up the sleeves and get the job done.

At Zealand, we understand the value of a diverse workforce. As an employee, you will be part of an innovative, cross-disciplinary, and cross-cultural working environment.

We offer a combined compensation package which includes a base salary, pension, bonus, and an attractive employee share program. We care about our employees’ well-being and offer health insurance, use of massage, fitness, and a range of social clubs and activities. To find out more about working at Zealand, visit


Please apply no later than March 27, 2023, or as soon as possible. The applications will be reviewed as they come in.

For further information, please contact Lars Stenholt, Vice President, Device Development

About Zealand Pharma A/S

Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of innovative peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals. Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit or follow Zealand on LinkedIn or Twitter @ZealandPharma.